Content Matter Expert
- Peter Johnson, Pharm.D., BCPPS, BCPS, FCCM, FPPAG
- Jamie Miller, Pharm.D., BCPPS, BCPS, FPPAG
- Jennifer Thackray, Pharm.D., BCPPS, BCPS
Faculty
Emily Chen, PharmD, BCPPS
Clinical Pharmacist, Pediatrics
UVA Health
Literature Studies
Dr. Emily Chen received her PharmD at Ernest Mario School of Pharmacy in 2001 and went on to complete a PGY1 pharmacy residency at Robert Wood Johnson University Hospital. Shortly thereafter she moved to Charlottesville and began her clinical career at UVA Health as a General Neurology Pharmacist. In 2009, she joined the Pediatric Pharmacy team under the tutelage of Marcia Buck, PharmD, BCPPS, and in 2017 achieved Board Certification in Pediatric Pharmacotherapy. Since joining the Pediatric Pharmacy team, Emily has helped to develop three additional clinical service lines, participated in the training of pharmacy and medical residents, has been involved in select Children’s Hospital Guideline development, and research and quality projects related to hematology/oncology and infectious disease. Emily is currently interested in further developing the pediatric hematology/ oncology and infectious disease pharmacy practice areas at UVA Health.
Kaitlin Hughes, PharmD, BCPPS
Clinical Pharmacist Pediatric Critical Care
Riley Hospital for Children at IU Health
Indianapolis, Indiana
Review and Recertification Course
Kaitlin Hughes, PharmD, BCPPS, is clinical pharmacist at Riley Hospital for Children. Her specialty practice area is pediatric critical care. She also serves as a preceptor for students from Purdue University and PGY1 and PGY2 residents at Indiana University Health. Dr. Hughes received her Pharm.D. from Purdue University in 2013. She completed her PGY1 pharmacy practice residency at Indiana University Health followed by her PGY2 pediatric pharmacy residency at University of Oklahoma College of Pharmacy. Dr. Hughes then attained her board certification as pediatric pharmacotherapy specialist (BCPPS) and worked as a clinical specialist in pediatric surgery and surgical critical care at CS Mott Children’s Hospital at Michigan Medicine for two years prior to relocating to Indianapolis. Her current interests include drug dosing in ECMO and renal replacement therapies, infectious diseases, pain management, and pain and sedation in the critically ill.
Peter N. Johnson, PharmD, BCPPS, BCPS, FCCM, FPPAG
Professor of Pharmacy Practice
University of Oklahoma College of Pharmacy
Review and Recertification Course, Literature Studies
Peter Johnson, PharmD, BCPPS, BCPS, FCCM, FPPAG, is a Professor of Pharmacy Practice at the OU College of Pharmacy and Adjunct Professor of Pediatrics at the OU College of Medicine. He also maintains an active practice site in the Medical and Cardiovascular Pediatric ICU’s at the Children’s Hospital at OU Medical Center (CHO) in Oklahoma City precepting PGY1/PGY2 residents and students. In addition, Dr. Johnson is a consultant for the Pediatric Pain Management Team at CHO. Dr. Johnson serves as the Residency Program Director for the PGY2 Pediatric Pharmacy Residency and Director of the Clinical and Translational Science Fellowship in Pediatric Pharmacotherapy at the OU College of Pharmacy and CHO. Dr. Johnson received his B.S. in Pharmaceutical Sciences and Doctor of Pharmacy degrees from the University of Mississippi School of Pharmacy. Following his tenure at Ole Miss, Dr. Johnson completed his PGY1 pharmacy and PGY2 pediatric pharmacy residencies at the University of Kentucky Chandler Medical Center. Among his professional affiliations, he is a member of the Pediatric Pharmacy Advocacy Group (PPAG), Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists, and American College of Clinical Pharmacy. Dr. Johnson is board certified in pharmacotherapy and pediatric pharmacy. In addition, he was inducted as a fellow of PPAG in 2016 and SCCM in 2018. His research/scholarship focuses in pain management, sedation, and drug withdrawal in children.
Zanette Kanani Bradley, PharmD, BCOP
Pediatric Oncology Clinical Pharmacist
Children's Hospital Colorado
Literature Studies
Dr. Zanette Kanani Bradley is a pediatric clinical pharmacist at Children’s Hospital Colorado and specializes in pediatric oncology. She received her Doctor of Pharmacy degree at University of Colorado School of Pharmacy and completed a PGY-1 Pharmacy Residency at Children’s Hospital Colorado. Dr. Kanani Bradley has worked as a clinical pharmacist in hematology/oncology since 2011. She built and established her current position as the ambulatory solid and liquid tumor oncology pharmacist. She serves as a primary preceptor for PGY-1 and PGY-2 residents as well as APPE students at Children’s Hospital Colorado. Dr. Kanani Bradley has been involved in numerous quality and safety initiatives at her institution such as expanding patient discharge teaching follow-up, implementing routine practice of pegaspargase pre-medications and therapeutic drug monitoring, and advancing pharmacy services in the ambulatory pediatric oncology patient setting.
Michelle Kussin, PharmD, BCOP
Clinical Pharmacist, Pediatric Infectious Diseases
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana
Core Therapeutic Modules
Michelle Kussin is a clinical pharmacist in pediatric infectious disease at Riley Hospital for Children at Indiana University Health in Indianapolis, Indiana. She also serves as Co-Director of the Pediatric Antimicrobial Stewardship (PAS) program and as Adjunct Assistant Professor of Pediatrics at Indiana University School of Medicine. She completed her Doctor of Pharmacy education at the South Carolina College of Pharmacy - Columbia Campus. She went on to complete a PGY-1 pharmacy practice residency at Boston Medical Center in Boston, MA, followed by a PGY-2 specialty residency in pediatric oncology at Memorial Sloan Kettering Cancer Center in New York City. She is a Board-Certified Oncology Pharmacist (BCOP) and has served as faculty for The American Society of Health-System Pharmacists and American College of Clinical Pharmacy (ASHP/ACCP) as the pediatric malignancies content expert. She is certified in antimicrobial stewardship serves as a preceptor for pharmacy residents, pediatric ID fellows, and students. Her practice interests include infectious disease in immunocompromised children, de-labeling penicillin allergies, utilizing electronic medical record to improve antibiotic prescribing, and pediatric pharmacokinetics.
Kevin Lonabaugh, PharmD, BCACP, AAHIVP, AE-C
Clinical Pharmacist - Pediatric Ambulatory Care
University of Virginia Children’s Hospital
Charlottesville, Virginia
Review and Recertification Course
Kevin Lonabaugh, Pharm.D., BCACP, AAHIVP, AE-C, is currently a clinical pharmacist practicing in pediatric ambulatory care at the University of Virginia Children's Hospital. His current clinics include the pulmonology, hematology/oncology, and general pediatrics clinics and he serves as a consult for other ambulatory clinical needs. Dr. Lonabaugh completed his Pharm.D. at Shenandoah University before completing a PGY1 Pharmacy Residency at the University of Virginia and a PGY2 Ambulatory Care Pharmacy residency at the University of Oklahoma College of Pharmacy. He serves as a preceptor for the PGY1 Pharmacy program at UVA as well as the PGY2 Pediatrics and Ambulatory Care programs. His interests include optimizing patient education and communication.
Mya Merrow, PharmD, BCOP
Pediatric Oncology Clinical Pharmacist
Children's Hospital Colorado
Aurora, Colorado
Review and Recertification Course
Dr. Mya Merrow is currently a pediatric clinical pharmacist at Children’s Hospital Colorado and specializes in pediatric hematology/oncology. She received her Doctor of Pharmacy degree at University of Tennessee Health Science Center and completed a PGY-1 Pharmacy Residency at Children’s Hospital Colorado in Aurora, Colorado. Dr. Merrow serves as a primary preceptor for PGY-1 and PGY-2 residents as well as APPE students at Children’s Hospital Colorado. Additionally, she is a guest lecturer in the Pediatric Elective at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science. She is Board Certified in Oncology Pharmacy and has worked as a clinical pharmacist in hematology/oncology since 2015. Dr. Merrow has been involved in numerous quality and safety initiatives at her institution such as expanding patient medication education, decreasing nephrotoxin-induced acute kidney injury, and improving inpatient chemotherapy admission processes.
Rachel S. Meyers, PharmD, BCPPS, BCPS, FPPAG
Clinical Associate Professor
Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey
Pediatric Pharmacist
Saint Barnabas Medical Center
Review and Recertification Course
Rachel Meyers, PharmD, BCPPS, BCPS, FPPAG, is a Clinical Associate Professor at the Ernest Mario School of Pharmacy at Rutgers University, and the Pediatric Clinical Pharmacist at Saint Barnabas Medical Center in Livingston, New Jersey. Dr. Meyers completed her undergraduate degree at the University of Mary Washington and her Doctor of Pharmacy degree at the University of Connecticut. After graduation she completed a PGY-1 residency at the University of Wisconsin Hospital and Clinics in Madison, Wisconsin, and a PGY-2 residency in Pediatric Pharmacotherapy at the University of North Carolina Children’s Hospital in Chapel Hill, North Carolina. In her current position, Dr. Meyers provides both didactic and experiential education in pediatric pharmacotherapy for pharmacy students and residents. She practices in the Pediatric Intensive Care Unit and General Pediatric Unit at Saint Barnabas Medical Center. Her research interests include pediatric critical care, infectious diseases, and dosage forms for children.
Jamie L. Miller, PharmD, BCPPS, BCPS, FPPAG
Associate Professor
University of Oklahoma College of Pharmacy
Review and Recertification Course, Literature Studies
Jamie Miller, Pharm.D., BCPS, BCPPS, is an Associate Professor in the Department of Pharmacy Clinical and Administrative Sciences at the University of Oklahoma College of Pharmacy in Oklahoma City, Oklahoma. Dr. Miller received her Doctor of Pharmacy degree from Southwestern Oklahoma State University College of Pharmacy. Following graduation, Dr. Miller completed a PGY1 Pharmacy Practice Residency and PGY2 Pediatric Pharmacy Practice Residency at the University of Oklahoma College of Pharmacy. Dr. Miller currently practices as a Clinical Pharmacy Specialist in the Neonatal Intensive Care Unit at the Children’s Hospital at OU Medical Center in Oklahoma City. In addition, Dr. Miller is the Residency Program Director for the PGY1 Pharmacy Residency at the University of Oklahoma College of Pharmacy and OU Medical Center.
Misty Miller, PharmD, BCPS
Associate Professor
University of Oklahoma College of Pharmacy
Literature Studies
Misty Miller, PharmD, BCPS, graduated from the University of Oklahoma College of Pharmacy and stayed on to complete two years of residency, specializing in Pediatrics. She currently serves adult and pediatric patients infected with HIV at the Infectious Diseases Institute and as an associate professor at OU.
Jill Morgan, PharmD, BCPPS, BCPS
Professor and Chair
University of Maryland School of Pharmacy
Review and Recertification Course
Jill A. Morgan, PharmD, BCPPS, BCPS, is a Professor and the Chair for Pharmacy Practice and Science at the University of Maryland School of Pharmacy in Baltimore. Dr. Morgan received a Doctor of Pharmacy degree from the University of Illinois at Chicago and completed PGY1 Pharmacy Practice and PGY2 Pediatrics residencies at the University of Maryland Medical Center in Baltimore. Dr. Morgan’s current practice is in general pediatrics and in ambulatory care in a pediatric gastrointestinal and surgery clinics. She is also the Director, Pediatric Fellowship Program at the University of Maryland School of Pharmacy.
Lane Nguyen, PharmD, BCPPS
Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, New York
Literature Studies, Core Therapeutic Modules
Lane Nguyen is a Board Certified Pediatric Pharmacist specializing in Critical Care Medicine. Dr. Nguyen provides support in pharmacotherapy for critically ill infants, children and young adults as a member of the Pediatric Intensive Care Unit. Their team in the PICU is staffed with pediatricians, nurse practitioners and nurses who focus their clinical efforts on the needs of critically ill infants, children and young adults. The team works closely with the pediatric surgeons, neurosurgeons, oncologists, bone marrow transplant specialists, pharmacists, respiratory care specialists and dietitians at MSK to ensure that patients get the excellent multidisciplinary care they need and deserve. Dr. Nguyen is committed to the education of future Pharmacists and serves as the primary PICU preceptor for Pharm.D. residents and students at Memorial Sloan Kettering Cancer Center.
Sarah Parsons, PharmD, BCPPS
Clinical Pharmacy Specialist
The Children's Hospital of the King's Daughters
Literature Studies
Dr. Parsons is the Pediatric Clinical Pharmacy Specialist of Infectious Diseases, Antimicrobial Stewardship, and Cystic Fibrosis at The Children's Hospital of the King's Daughters (CHKD) and serves as an Assistant Professor for the Department of Pediatrics At Eastern Virginia Medical School. at the Children`s Hospital of The King`s Daughters. She received Doctor of Pharmacy Degree from Virginia Commonwealth School of Pharmacy. Dr. Parsons completed a PGY1 residency with a focus in pediatrics at HCA Health system in Richmond Virginia. Prior to relocating to Norfolk, she worked as a pediatric pharmacy specialist in the neonatal and pediatric intensive care units at the University of Virginia Children`s Hospital (UVA-CH) in Charlottesville Virginia for 6 years. At UVA-CH, she implemented pediatric ambulatory care services in the cystic fibrosis clinic and pharmacist lead pharmacokinetics services. At CHKD, Dr. Parsons is the antimicrobial stewardship program co-lead and a member of the cystic fibrosis care team, participating on daily rounds, patient care conferences, and serves as an infectious diseases expert. Dr. Parsons is available by direct consultation and manages pharmacokinetic drug therapy in addition to medication policies, guidelines, and references. She has a special interest in multi-drug resistant pathogens and pharmacokinetics, nontuberculous mycobacterium infections, and SAR-CoV-2 related infections. Dr. Parsons is a leading member of the hospital wide COVID-19 management team, presented multiple lectures nationally, and authored multiple peer-review publications on the management of COVID-19 and associated complications in children. Additionally, Dr. Parsons has presented internationally and nationally on the management of nontuberculous mycobacterium in patients with cystic fibrosis. Furthermore, she designed the current treatment guidelines for COVID-19 in children and the treatment guidelines for Multisystem inflammatory syndrome in children (MIS-C) at CHKD, which have been presented to the Virginia Academy of Pediatrics, nationally, and references in peer-reviewed publications. Dr. Parsons has been recognized nationally by the academy of clinical pharmacy (ACCP) for her efforts and is currently nominated to receive the 2022 Inside Business Health Care Hero Award.
Nicole Palazzolo, PharmD, BCPPS
Clinical Pharmacist - Pediatric and Neonatal Critical Care
University of Virginia Children's Hospital
Literature Studies
Dr. Palazzolo serves as a pediatric clinical pharmacist, working primarily in the Neonatal ICU, at the University of Virginia Children's Hospital in Charlottesville, VA. Palazzolo also serves as a Clinical Assistant Professor and preceptor for pharmacy students at VCU School of Pharmacy and has been a board certified pediatric pharmacist since 2019. Prior to starting her pharmacy career at UVA, Palazzolo completed two years of pediatric residency at LeBonheur Children's Hospital and the University of Tennessee Health Science Center in Memphis, TN and attended pharmacy school at the University of North Carolina Eshelman School of Pharmacy in Chapel Hill, NC.
Ashley Sabus, PharmD, BCOP
Clinical Pharmacist - Pediatric Hematology/Oncology
Children's Hospital Colorado
Literature Studies
Ashley Sabus, PharmD, BCOP is an Ambulatory Pediatric Hematology/Oncology clinical pharmacist at Children’s Hospital Colorado. She received her Doctor of Pharmacy degree from The University of Iowa College of Pharmacy and completed a PGY1 and PGY2 pharmacy practice residency in pediatrics at Children’s Hospital Colorado. Dr. Sabus is involved in experiential education as an Advanced Pharmacy Practice preceptor and she presents an annual guest lecture on Sickle Cell Disease for the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. She specializes in pharmacotherapy for pediatric patients with brain tumors and non-malignant hematologic disorders. As part of her commitment to advancing the care of this patient population, she has led a variety of quality improvement projects, such as creation of an iron chelator monitoring guideline and CNS tumor roadmap refresh project. She has authored peer-reviewed publications and delivered national and local poster presentations. Examples of her recent work include a review of safety in concomitant use of MEK and BRAF inhibitors with bevacizumab, a single institution’s report of the drug interaction between everolimus and cannabidiol in pediatric patients with subependymal giant cell astrocytomas, and a pharmacotherapy review article on the management of self-injurious behaviors in children with neurodevelopmental disorders.
Sana Said, PharmD, BCPPS
Clinical Pharmacy Specialist - PICU
University of Chicago Medicine - Comer Children's Hospital
Literature Studies
Dr. Said is a clinical pharmacy specialist for the pediatric intensive unit at Comer Children’s Hospital. She also serves as the residency program coordinator of the University of Chicago Medicine’s PGY1 pharmacy residency program. She received her PharmD from the University of Illinois at Chicago’s College of Pharmacy. Dr. Said then completed both her PGY1 pharmacy residency and PGY2 pediatric pharmacy residency at the University of Illinois Hospital and Health Sciences System.
Pooja Shah, PharmD, BCPS
Clinical Associate Professor, Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Literature Studies
Pooja Shah is a Clinical Associate Professor at the Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey and a Clinical Pharmacy Specialist in Neonatal Intensive Care and Pediatric Pharmacotherapy at the Joseph M Sanzari Children's Hospital at Hackensack University Medical Center. She received her Doctorate in Pharmacy at the Ernest Mario School of Pharmacy at Rutgers University, completed her PGY-1 at Hackensack University Medical Center and PGY-2 in Pediatrics at the University of Chicago in Illinois. She is a currently an active member of the Pediatric Pharmacy Advocacy Group and American Society of Health Systems Pharmacy.
Jennifer Thackray, Pharm.D., BCPPS, BCPS
Pediatric Oncology Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
Review and Recertification Course, Literature Studies
Jennifer Thackray, Pharm.D., BCPPS, BCPS, is a Pediatric Oncology Clinical Pharmacy Specialist at Memorial Sloan Kettering Cancer Center (MSK) in New York, NY. Dr. Thackray earned her Doctor of Pharmacy degree from The University of Oklahoma College of Pharmacy in 2009. She completed an ASHP-accredited PGY1 Pharmacy Practice Residency (2010) and a PGY2 Pediatric Pharmacotherapy Specialty Residency (2011) at the University of North Carolina Health Clinics in Chapel Hill, NC. Dr. Thackray is board certified in pharmacotherapy and pediatric pharmacotherapy. Dr. Thackray joined the MSK Department of Pharmacy in 2011, initially practicing in the pediatric oncology inpatient setting. Over her tenure at MSK, Dr. Thackray has assisted in developing pediatric clinical services in the outpatient leukemia clinic and the outpatient sarcoma clinic. Her clinical practice includes rotating between inpatient oncology, outpatient leukemia and outpatient neuro-oncology clinical services. Currently, Dr. Thackray serves as a clinical preceptor in these areas, a PGY2 resident mentor and a research mentor for PGY2 resident research projects. Dr. Thackray's clinical interests and research efforts include pediatric oncology supportive care measures (i.e., chemotherapy-induced nausea and vomiting, venous thromboembolism, menses suppression, etc), pharmacogenetics and clinical guideline development within international organizations. Dr. Thackray is an active member of the American Society of Health-System Pharmacists (ASHP), American College of Clinical Pharmacy (ACCP), Children’s Oncology Group (COG), Clinical Pharmacogenetics Implementation Consortium (CPIC), Hematology/Oncology Pharmacy Association (HOPA) and Pediatric Pharmacy Advocacy Group (PPAG).
Lisa Thames, Pharm.D., BCPS
Assistant Director, Inpatient Pharmacy Services
UF Health Shands Hospital
Review and Recertification Course
Lisa Thames, Pharm.D., BCPS, is Assistant Director, Inpatient Pharmacy Services and Director, Education Programs at UF Health Shands Hospital in Gainesville, Florida. In addition, Dr. Thames serves as Clinical Assistant Professor at the University of Florida College of Pharmacy.
Dr. Thames earned her Doctor of Pharmacy degree from the University of Florida College of Pharmacy. She completed her PGY1 Residency and PGY2 Pediatric Residency at University of Kentucky Healthcare. Dr. Thames formerly served as a Pediatric Intensive Care Unit clinical pharmacy specialist, Pediatric Medication Safety & Quality clinical pharmacy specialist, PGY1 residency program co-director, Chief of Pediatric Pharmacy Services, and PGY2 Pediatrics residency program director at UF Health Shands Hospital prior to her current role as Assistant Director of Inpatient Pharmacy Services.
Dr. Thames has held various leadership positions including past Secretary and President of the North Central Florida Society of Health System Pharmacists (NCFSHP), founding steering committee member and past Chair of the regional Florida Residency Conference (FRC), council member on the UHC Pediatric Pharmacy Committee, and Board of Director for FSHP. Dr. Thames’ primary areas of interest include pediatric medication safety and pharmacy leadership.
